Suppr超能文献

用于预防和治疗血管疾病的药物引起的血脂异常。

Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases.

作者信息

Tziomalos Konstantinos, Athyros Vasilios G, Karagiannis Asterios, Mikhailidis Dimitri P

机构信息

Department of Clinical Biochemistry (Vascular Prevention Clinic) and Department of Surgery, Royal Free Campus, University College London Medical School, University College London (UCL), London, UK.

出版信息

Open Cardiovasc Med J. 2011;5:85-9. doi: 10.2174/1874192401105010085. Epub 2011 Feb 24.

Abstract

Dyslipidemia is a major vascular risk factor. Interestingly, several agents used for the prevention and treatment of vascular diseases have an adverse effect on the lipid profile. In addition, agents belonging to the same class (e.g. beta blockers) can have significantly different actions on lipid levels. We summarize the effects of drugs used for the prevention and treatment of vascular diseases on the lipid profile. These effects should be considered when selecting a specific agent, particularly in high-risk patients.

摘要

血脂异常是主要的血管危险因素。有趣的是,几种用于预防和治疗血管疾病的药物对血脂谱有不良影响。此外,属于同一类别的药物(如β受体阻滞剂)对血脂水平的作用可能有显著差异。我们总结了用于预防和治疗血管疾病的药物对血脂谱的影响。在选择特定药物时,尤其是在高危患者中,应考虑这些影响。

相似文献

7
Nonfasting Lipid Profile May Suffice to Manage Dyslipidemia.非空腹血脂谱可能足以用于管理血脂异常。
Indian J Psychol Med. 2020 Apr 25;42(3):316-317. doi: 10.4103/IJPSYM.IJPSYM_178_20. eCollection 2020 May-Jun.
8
[Antihypertensive therapy and lipid metabolism].[抗高血压治疗与脂质代谢]
Klin Wochenschr. 1984 Mar 1;62(5):193-202. doi: 10.1007/BF01721044.
10
Atherogenic dyslipidemia: prevalence and management in lipid clinics.
Rev Clin Esp (Barc). 2014 Dec;214(9):491-8. doi: 10.1016/j.rce.2014.06.001. Epub 2014 Jul 9.

本文引用的文献

5
Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus.
Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):16-7. doi: 10.1038/ncpendmet1021. Epub 2008 Nov 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验